IMDX vs MSFT: Which Stock is Better?
Side-by-side comparison of Insight Molecular Diagnostics Inc. and Microsoft Corporation in 2026
IMDX
Insight Molecular Diagnostics Inc.
$3.84
MSFT
Microsoft Corporation
$495.83
Key Metrics Comparison
| Metric | IMDX | MSFT | Winner |
|---|---|---|---|
| Market Cap | N/A | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MSFT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze IMDX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMDX or MSFT a better investment?
Comparing IMDX and MSFT: Insight Molecular Diagnostics Inc. has a market cap of N/A while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMDX and MSFT?
IMDX (Insight Molecular Diagnostics Inc.) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMDX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMDX or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for IMDX.
Which company is more profitable: IMDX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for IMDX.
Which is the larger company: IMDX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to N/A for IMDX.
Should I buy IMDX or MSFT in 2026?
Both IMDX and MSFT have investment merit. IMDX trades at $3.84 while MSFT trades at $495.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMDX and MSFT stock?
Key differences: Market Cap (N/A vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy IMDX or MSFT in 2026?
The choice between IMDX and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between IMDX and MSFT?
IMDX (Insight Molecular Diagnostics Inc.) has a market cap of N/A, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.